Galderma Group AG
F:PY30
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Galderma Group AG
F:PY30
|
CH |
|
L
|
Lynas Rare Earths Ltd
XHAM:LYI
|
MY |
|
E
|
Equinor ASA
SWB:DNQ
|
NO |
|
Mora Telematika Indonesia Tbk PT
IDX:MORA
|
ID |
|
M
|
Medtronic PLC
F:2M6
|
IE |
Galderma Group AG
Galderma Group AG is a skin-health company that focuses on treatments and products for the skin, face, and body. It sells prescription dermatology medicines, injectable aesthetic treatments, and over-the-counter skin care products. Its portfolio includes products used by dermatologists, medical professionals, and consumers who want help with conditions such as acne, rosacea, eczema, and age-related skin concerns. The company makes money by selling these products through healthcare channels, clinics, pharmacies, and consumer retail outlets, depending on the product type. Prescriptions and physician-administered treatments are aimed at medical practices and aesthetic clinics, while its skin care brands are sold more broadly to everyday shoppers. This gives Galderma a mix of professional, clinic-based, and consumer revenue streams. What makes Galderma different is that it sits at the intersection of medicine and beauty. It is not just a drug maker or a cosmetics company; it focuses specifically on skin health and aesthetic dermatology, where treatment and appearance often overlap. That position gives it a clear role in the value chain for skin specialists, injectors, and consumers looking for trusted products backed by dermatology expertise.
Galderma Group AG is a skin-health company that focuses on treatments and products for the skin, face, and body. It sells prescription dermatology medicines, injectable aesthetic treatments, and over-the-counter skin care products. Its portfolio includes products used by dermatologists, medical professionals, and consumers who want help with conditions such as acne, rosacea, eczema, and age-related skin concerns.
The company makes money by selling these products through healthcare channels, clinics, pharmacies, and consumer retail outlets, depending on the product type. Prescriptions and physician-administered treatments are aimed at medical practices and aesthetic clinics, while its skin care brands are sold more broadly to everyday shoppers. This gives Galderma a mix of professional, clinic-based, and consumer revenue streams.
What makes Galderma different is that it sits at the intersection of medicine and beauty. It is not just a drug maker or a cosmetics company; it focuses specifically on skin health and aesthetic dermatology, where treatment and appearance often overlap. That position gives it a clear role in the value chain for skin specialists, injectors, and consumers looking for trusted products backed by dermatology expertise.
